PTP4A3 and cancer: Nanobodies have also emerged as a valuable tool to neutralize target proteins involved in disease, including SARS-CoV-2 [59]—delivery of anti-PRL-3 nanobodies into the cell would position it as a useful biological therapeutic in a variety of cancers.